|
||||
|
|
Chinese Journal of Obstetric Emergency(Electronic Edition) >
2015 , Vol. 04 >Issue 01: 44 - 47
DOI: https://doi.org/10.3877/cma.j.issn.2095-3259.2015.01.010
Management of fetal－maternal hemorrhage of RhD isoimmunization during pregnancy
Fetal-maternal hemorrhage of RhD isoimmunization is maternal antibodies of Rh-negative pregnant woman affecting the RhD red cell antigen of Rh-positive fetus, which may result in hemolytic disease of the fetus/newborn, even stillbirth. Prior to the use of anti-D immune globulin, the incidence rate of the fetus/newborn hemolytic disease is high. Implement RhD immune globulin prophylaxis normatively and monitor fetal during pregnancy carefully can led to a significant reduction in the frequency of perinatal mortality and morbidity.
Yan Yin , Qiying Zhu . Management of fetal－maternal hemorrhage of RhD isoimmunization during pregnancy[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2015 , 04(01) : 44 -47 . DOI: 10.3877/cma.j.issn.2095-3259.2015.01.010
| [1] | Bolton-Maggs PH, Davies T, Poles D, et al. Errors in anti-D immunoglobulin administration: retrospective analysis of 15 years of reports to the UK confidential haemovigilance scheme[J]．Int J Obstet Gynaecol, 2013，120(7):873-878. |
| [2] | Abdel-Fattah SA, Soothill PW, Carroll SG, et al. Middle cerebral artery Doppler for the prediction of fetal anaemia in cases without hydrops: a practical approach[J]. Br J Radiol, 2002, 75(897):726-730. |
| [3] | Daniels G. Variants of RhD--current testing and clinical consequences[J]. Br J Haematol, 2013, 16(14):461-470. |
| [4] | 田兆嵩. 临床输血学[M]. 2版. 北京：人民卫生出版社，2002: 178. |
| [5] | Bowman JM. Controversies in Rhprophylaxis: who needs Rhimmune globulin and when should it be given？[J]. Am J Obstet Gynecol, 1985, 151(3):289-294. |
| [6] | Bowman J. Rh-immunoglobulin: Rhprophylaxis[J]. Best Pract Res Clin Haemato, 2006, 19(1):27-34. |
| [7] | American College Obstetricians, Gynecologists, American Academy of Pediatrics. Guidelines for Perinatal Care[M]. 7th ed. Washington: Amer Academy of Pediatrics, 2012：164-167. |
| [8] | Tynan JA, Angkachatchai V, EhrichM, et al. Multiplexed analysis of circulating cell-free fetal nucleic acids for noninvasive prenatal diagnostic RHD testing[J]. Am J Obstet Gynecol, 2011, 204(3):251.e1-e6. |
| [9] | Mari G, Deter RL, Carpenter RL, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses[J]. N Engl J Med, 2000, 342(1):9-14. |
| [10] | Oepkes D, Seaward PG, Vandenbussche FP, et al. Doppler ultrasonography versus amniocentesis to predict fetal anemia[J]. N Engl J Med, 2006, 355(2):156-164. |
| [11] | Zipursky A, Paul VK. The global burden of Rh disease[J]．Arch Dis Child Fetal Neonatal Ed, 2011, 96(2):F84-F85. |
| [12] | Coopamah MD, Freeman J, Semple JW. Anti-D initially stimulates an Fc-dependent leukocyte oxidative burst and subsequently suppresses erythrophagocytosis via interleukin-1 receptor antagonist[J]. Blood, 2003, 102(8):2862-2867. |
| [13] | Boruchov AM, Heller G, Veri MC, et al. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions[J]. J Clin Invest, 2005, 115(10):2914-2923. |
| [14] | Kumpel BM. On the mechanism of tolerance to the Rh D antigen mediated by passive anti-D (Rh D prophylaxis)[J]. Immunology Letters, 2002, 82(1-2):67-73. |
| [15] | Daniels G. Variants of RhD--current testing and clinical consequences[J]. Br J Haematol, 2013, 161(4):461-470. |
| [16] | Cunningham FG, Leveno KJ, Bloom SL, et al. Williams obstetrics[M]. 24th ed. New York: McGraw-Hill Education, 2014：312. |
| [17] | Chambers E, Davies L, Evans S, et al. Comparison of haemoglobin F detection by the acidelution test, flow cytometry and high-performance liquidchromatography in maternal blood samples analysed for fetomaternal haemorrhage[J]. Transfus Med, 2012, 22(3):199-204. |
| [18] | Chilcott J, Lloyd JM, Wight J, et al. A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus-negative[J]. Health Technol Assess, 2003, 7(4):iii-62. |
| [19] | Kent J, Farrell AM, Soothill P. Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice[J]. BMC Pregnancy Childbirth, 2014, 14:87. |
| [20] | Fox C, Martin W, Somerset DA, et al. Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunization prior to fetal intravascular transfusion[J]. Fetal Diagn Ther, 2008, 23(2):159-163. |
| [21] | Scheier M, Hernandez-Andrade E, Fonseca EB, et al. Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusion[J]. Am J Obstet Gynecol, 2006，195 (6):1550-1556. |
| [22] | van Kamp IL, Klumper FJ, Oepkes D, et al. Complications of intrauterine intravascular transfusion for fetalanemia due to maternalred-cellalloimmunization[J]. Am J Obstet Gynecol, 2005, 192(1):171-177. |
| [23] | Lindenburg IT, van Kamp IL, van Zwet EW, et al. Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation[J]. BJOG, 2013, 120(7):847-852. |
| [24] | Lindenburg IT, Smits-Wintjens VE, van Klink JM, et al. Long-term neurodevelopmentaloutcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study[J]. Am J Obstet Gynecol, 2012, 206(2):141.e1-e8. |
/
| 〈 |
|
〉 |
|
京ICP 备07035254号-20 Copyright © Chinese Journal of Obstetric Emergency(Electronic Edition), All Rights Reserved. Tel: 020-81256537 E-mail: chankejijiuzazhi@163.com Powered by Beijing Magtech Co. Ltd |